# Safety, Tolerability and Pharmacokinetic Profiles of MOTREM (LR12) in Healthy Male Subjects

> **NCT03463044** · PHASE1 · COMPLETED · sponsor: **Inotrem** · enrollment: 27 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** nangibotide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03463044
- **Lead sponsor:** Inotrem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2016-08-25
- **Final completion:** 2016-08-25
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03463044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03463044, "Safety, Tolerability and Pharmacokinetic Profiles of MOTREM (LR12) in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03463044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*